Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Agache (Brasov/Brasov, Romania). Monitoring the inflammatory heterogeneity in asthma with multiple biomarkers for multidimensional endotyping. 579

Member's Comments

No comment yet.

Related content which might interest you: Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Overview and history of different ways of assessing and monitoring inflammatory airway diseases Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease Year: 2017 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 Searching for inflammatory and oxidative-stress markers capable of clustering severe asthma. Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018 Why inflammatory phenotyping is necessary for successful drug evaluation in asthma and COPD Source: Eur Respir J 2013; 42: 891-892 Year: 2013 Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 The identification of asthma phenotypes by categorical PCA: Combinatorial analysis of clinical parameters and dysfunctional blood eosinophils Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Th-17 cytokine profile in a Greek asthmatic population. Correlation with asthma severity and biomarkers of inflammation. Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness Source: International Congress 2014 – COPD: points to ponder Year: 2014 Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 Identifying systemic inflammatory markers in the Melbourne COPD exacerbation cohort Source: Eur Respir J 2005; 26: Suppl. 49, 51s Year: 2005 Asthma endotypes: a new approach to classification of disease entities within asthma Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping Year: 2013 Concordance in temporally distinct blood and sputum inflammatory phenotypic measures in severe asthma Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label Source: Eur Respir J, 51 (1) 1701817; 10.1183/13993003.01817-2017 Year: 2018 Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma Source: Eur Respir J 2006; 28: Suppl. 50, 122s Year: 2006 Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes Source: Eur Respir J 2015; 46: 688-696 Year: 2015 Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011